Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0NH1E
|
||||
Former ID |
DIB000651
|
||||
Drug Name |
Org-231295
|
||||
Synonyms |
KDS-1243; KDS-4103; URB-597; FAAH inhibitor, Merck & Co; FAAH inhibitor, Schering-Plough/Kadmus/university of California
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Anxiety disorder [ICD9: 300, 311; ICD10:F32, F40-F42] | Investigative | [467677] | ||
Company |
University of California
|
||||
Structure |
Download2D MOL |
||||
Formula |
C20H22N2O3
|
||||
InChI |
InChI=1S/C20H22N2O3/c21-19(23)16-8-4-6-14(12-16)15-7-5-11-18(13-15)25-20(24)22-17-9-2-1-3-10-17/h4-8,11-13,17H,1-3,9-10H2,(H2,21,23)(H,22,24)
|
||||
InChIKey |
ROFVXGGUISEHAM-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
1712159, 4117632, 6954439, 8844535, 14875581, 26758692, 29217673, 39816644, 47204541, 50076611, 50622803, 53790751, 53800779, 56365487, 57298451, 57409005, 89062649, 103455066, 103867351, 105221266, 110370747, 118265378, 124360783, 124582512, 125160794, 125164696, 125334103, 131318389, 134345885, 135246806, 135367488, 135683180, 136340244, 136349528, 136367659, 136373638, 137125269, 137189432, 139529511, 152258271, 152344299, 160647108, 162011484, 162035022, 162194395, 163125113, 163688151, 164194104, 164195801, 165437862
|
||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [543418] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.